Inflammatory bowel disease reveals the kinase activity of KSR1 Journal Article


Authors: Kolesnick, R.; Xing, H. R.
Article Title: Inflammatory bowel disease reveals the kinase activity of KSR1
Abstract: Kinase suppressor of Ras-1 (KSR1) is a recently identified member of the EGFR-Ras-Raf-1-MAPK signaling pathway. A new study demonstrates that KSR1 protects intestinal epithelium from TNF-α-induced apoptosis, abrogating inflammatory bowel disease (IBD) (see the related article beginning on page 1272). Since its discovery, there has been disagreement as to whether KSR1 possesses intrinsic kinase activity. Using transgenic mouse models and genetically modified mouse colon epithelial cells, Polk and coworkers show that the kinase activity of KSR1 is off in normal colon epithelial cells, becoming activated only at the onset of IBD. They also provide strong evidence that KSR1 kinase activity is essential for anti-apoptotic protection of the intestinal epithelium. These new data in support of KSR1 as a kinase highlight an ongoing debate as to whether KSR1 does indeed serve as a specific kinase in transphosphorylating and transactivating c-Raf-1 toward MEK1.
Keywords: signal transduction; mitogen activated protein kinase; protein expression; unclassified drug; review; raf protein; nonhuman; note; protein function; mouse; metabolism; apoptosis; biological model; models, biological; mitogen activated protein kinase kinase 1; protein kinases; epidermal growth factor receptor; enzyme activation; enzymology; pathology; enzyme activity; physiology; transgenic mouse; disease model; enzyme phosphorylation; tumor necrosis factor alpha; transactivation; epithelium cell; epithelial cells; enteritis; ras protein; inflammatory bowel diseases; protein kinase; colon; map kinase kinase 1; kinase suppressor of ras 1; proto-oncogene proteins c-raf; colon mucosa; protection; trans-activation (genetics); ksr 1 protein kinase; ksr-1 protein kinase; intestine epithelium; humans; human; priority journal
Journal Title: Journal of Clinical Investigation
Volume: 114
Issue: 9
ISSN: 0021-9738
Publisher: American Society for Clinical Investigation  
Date Published: 2004-11-01
Start Page: 1233
End Page: 1237
Language: English
DOI: 10.1172/jci23441
PROVIDER: scopus
PMCID: PMC524240
PUBMED: 15520853
DOI/URL:
Notes: J. Clin. Invest. -- Cited By (since 1996):18 -- Export Date: 16 June 2014 -- CODEN: JCINA -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Hongmei Xing
    12 Xing
  2. Richard N Kolesnick
    298 Kolesnick